Plan B Pharmacy Access Movement Likely To Be Further Fueled By FDA Delay
This article was originally published in The Tan Sheet
Executive Summary
State legislative efforts to make Barr's Plan B available directly from pharmacists will likely increase following FDA's latest deferral of a decision on the Rx-to-OTC switch of the drug